 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|||||||||||||||
 |
 |
 |
|
|||||||||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|||
 |
|
|||||||||||||||
 |
|
|||||||||||||||
- 2012 Press Releases
- 2011 Press Releases
- 2010 Press Releases
- 2009 Press Releases
- 2008 Press Releases
- Financial Filings
Titan Stock Quotes
May 11, 2012 - Titan Pharmaceuticals Announces First Quarter 2012 Financial Results |
 |
May 9, 2012 - Titan Pharmaceuticals Schedules Conference Call to Review First Quarter 2012 Financial Results |
|
April 20, 2012 - Titan Pharmaceuticals Announces Phase 3 Probuphine®Data Presentation At The American Society Of Addiction Medicine (ASAM) 43Rd Medical-Scientific Conference |
|
April 10, 2012 - Titan Pharmaceuticals to Raise $5.5 Million in Registered Direct Offering |
|
March 16, 2012 - Titan Pharmaceuticals Announces Fourth Quarter and Year-End 2011 Financial Results |
|
March 14, 2012 - Titan Pharmaceuticals Schedules Conference Call to Review Fourth Quarter and Full Year 2011 Financial Results |
|
February 9, 2012 - Titan Pharmaceuticals Announces Positive Results of Six-Month Open-Label Safety Retreatment Study Of Probuphine |
|
February 7, 2012 - Titan Pharmaceuticals to Present at 14th Annual BIO CEO & Investor Conference |
|